Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 22
1.
Clin. transl. oncol. (Print) ; 23(8): 1571-1576, ago. 2021. graf
Article En | IBECS | ID: ibc-222155

Purpose We aimed to evaluate the prognostic value of 18F-FDG PET/CT in patients with relapsed or refractory T-Lymphoblastic lymphoma (T-LBL) undergoing hematopoietic stem cell transplantation (HSCT). Methods PET/CT was performed in 21 consecutive relapsed or refractory T-LBL patients scheduled for HSCT. All PET/CT images were assessed using the Deauville criteria, and patients were divided into negative (Deauville ≤ 3) and positive (Deauville > 3) groups for comparison. The predictive value of sex, age, Ann Arbor stage, presence of B symptoms, lactate dehydrogenase level, presence of extranodal disease, and PET/CT results before and after HSCT were evaluated. Results Kaplan–Meier analysis showed that only PET/CT after HSCT (post-PET) was correlated with progression-free survival (PFS) (P = 0.030). The Cox regression model also showed that the post-PET-positive group had a higher hazard ratio (HR) than the negative group (HR = 3.884 and P = 0.049). However, none of the evaluated factors were predictive of overall survival (OS). Conclusions Pre-PET cannot predict the PFS and OS of patients with T-LBL undergoing HSCT, which means that 18F-FDG PET/CT cannot be used for identifying patients who can benefit from HSCT. Post-PET is not predictive for OS in patients with T-LBL undergoing HSCT. However, post-PET showed strong correlations with PFS, which means that it may be useful for guiding subsequent clinical treatment decisions (AU)


Humans , Male , Female , Adolescent , Young Adult , Adult , Hematopoietic Stem Cell Transplantation , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/therapy , Fluorodeoxyglucose F18 , Kaplan-Meier Estimate , Neoplasm Staging , Positron Emission Tomography Computed Tomography , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/mortality , Predictive Value of Tests , Prognosis , Retrospective Studies
2.
Clin Transl Oncol ; 23(8): 1571-1576, 2021 Aug.
Article En | MEDLINE | ID: mdl-33449269

PURPOSE: We aimed to evaluate the prognostic value of 18F-FDG PET/CT in patients with relapsed or refractory T-Lymphoblastic lymphoma (T-LBL) undergoing hematopoietic stem cell transplantation (HSCT). METHODS: PET/CT was performed in 21 consecutive relapsed or refractory T-LBL patients scheduled for HSCT. All PET/CT images were assessed using the Deauville criteria, and patients were divided into negative (Deauville ≤ 3) and positive (Deauville > 3) groups for comparison. The predictive value of sex, age, Ann Arbor stage, presence of B symptoms, lactate dehydrogenase level, presence of extranodal disease, and PET/CT results before and after HSCT were evaluated. RESULTS: Kaplan-Meier analysis showed that only PET/CT after HSCT (post-PET) was correlated with progression-free survival (PFS) (P = 0.030). The Cox regression model also showed that the post-PET-positive group had a higher hazard ratio (HR) than the negative group (HR = 3.884 and P = 0.049). However, none of the evaluated factors were predictive of overall survival (OS). CONCLUSIONS: Pre-PET cannot predict the PFS and OS of patients with T-LBL undergoing HSCT, which means that 18F-FDG PET/CT cannot be used for identifying patients who can benefit from HSCT. Post-PET is not predictive for OS in patients with T-LBL undergoing HSCT. However, post-PET showed strong correlations with PFS, which means that it may be useful for guiding subsequent clinical treatment decisions.


Hematopoietic Stem Cell Transplantation , Positron Emission Tomography Computed Tomography/methods , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/therapy , Adolescent , Adult , Age Factors , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cyclophosphamide/therapeutic use , Dexamethasone/therapeutic use , Doxorubicin/therapeutic use , Drug Resistance, Neoplasm , Female , Fluorodeoxyglucose F18 , Humans , Kaplan-Meier Estimate , L-Lactate Dehydrogenase/blood , Male , Neoplasm Staging , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/mortality , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Predictive Value of Tests , Prognosis , Progression-Free Survival , Proportional Hazards Models , Radiopharmaceuticals , Recurrence , Retrospective Studies , Sex Factors , Vincristine/therapeutic use , Young Adult
3.
World Neurosurg ; 142: 227-232, 2020 10.
Article En | MEDLINE | ID: mdl-32634638

BACKGROUND: T-cell lymphoblastic lymphoma (T-LBL) is a rare and aggressive form of non-Hodgkin lymphoma. This report describes, to our knowledge, the first adult case of a primary cauda equina T-LBL. Treatment consists of multiagent chemotherapy, and surgical removal of T-LBL does not improve outcome. We discuss the workup of patients with an intradural spinal mass, together with a review of the literature on primary spinal lymphoma of the cauda equina. CASE DESCRIPTION: A 54-year-old woman with Crohn's disease, for which she was taking immunosuppressive medication, presented with progressive back pain radiating to both legs and deteriorating neurologic deficits caused by an intradural, contrast-enhancing lesion in the L1-5 region. During acute surgery, the tumor was partially resected. Immunohistochemical phenotyping revealed a T-LBL. No other lymphoma localizations were found after subsequent staging. Despite extensive treatment, the patient died of disseminated disease throughout the central nervous system, 6 weeks after the diagnosis. CONCLUSIONS: Pain and progressive neurologic complaints can be symptoms of a (malignant) intradural spinal tumor. Intradural lymphoma must be considered as a differential diagnosis by clinicians because it can mimic neoplasms that often require urgent surgery. The histopathologic diagnosis should preferably be obtained by way of cerebrospinal fluid analysis or tumor biopsy because tumor resection has no beneficial effect on the oncologic outcome.


Cauda Equina/surgery , Lumbar Vertebrae/surgery , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Spinal Cord Neoplasms/surgery , Cauda Equina/diagnostic imaging , Female , Humans , Lumbar Vertebrae/diagnostic imaging , Middle Aged , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging , Spinal Cord Neoplasms/diagnostic imaging
6.
Orbit ; 38(5): 412-418, 2019 Oct.
Article En | MEDLINE | ID: mdl-30396307

The majority of ocular adnexal lymphomas are B-cell in origin. We report two cases of T-cell lymphoblastic lymphoma (T-LBL) involving the ocular adnexa. One patient presented with a painless pink conjunctival lesion and inferior orbital fullness. The second patient presented with a painless orbital mass. The diagnoses were confirmed by histopathology and immunohistochemistry. Both patients had extensive multifocal lesions during staging. Prompt intensified chemotherapy regimens were initiated. T-LBL is an aggressive disease with poor prognosis. This report emphasizes the importance of timely diagnosis by the ophthalmologist with co-management and treatment with an oncologist.


Conjunctival Neoplasms/pathology , Orbital Neoplasms/pathology , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Adult , Biomarkers, Tumor/metabolism , Biopsy , Conjunctival Neoplasms/diagnostic imaging , Conjunctival Neoplasms/metabolism , Conjunctival Neoplasms/surgery , Humans , Male , Neoplasm Proteins/metabolism , Orbital Neoplasms/diagnostic imaging , Orbital Neoplasms/metabolism , Orbital Neoplasms/surgery , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/surgery , Tomography, X-Ray Computed , Young Adult
8.
Br J Haematol ; 179(2): 294-297, 2017 10.
Article En | MEDLINE | ID: mdl-28961308

A 14-year-old boy with relapsed T cell acute lymphoblastic leukaemia received reinduction chemotherapy that included nelarabine, a purine nucleoside analogue known to cause dose-dependent neurotoxicity. Although he achieved aminimal residual disease negative remission after two cycles of chemotherapy he also developed severe, progressive peripheral and central neurotoxicities. Loss of grey-white differentiation was seen on a T2-weighted magnetic resonance imaging brain scan. This unusual clinical picture and previously unreported radiological findings are thought to be due to nelarabine toxicity. He was bridged with 6-mercaptopurine while transplant was deferred pending sustainable neurological improvement. This case posed clinical and ethical dilemmas while demonstrating previously unreported radiological features.


Arabinonucleosides/adverse effects , Brain/diagnostic imaging , Magnetic Resonance Imaging , Neurotoxicity Syndromes/diagnostic imaging , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Adolescent , Arabinonucleosides/administration & dosage , Humans , Male , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging
9.
Sci Rep ; 7(1): 2577, 2017 05 31.
Article En | MEDLINE | ID: mdl-28566711

Lymphomas involving the mediastinum occur in a wide age range and represent heterogeneous histological subtypes with various clinical symptoms and complex radiological findings. However, studies that describe the clinical and radiological features of different subtypes among Chinese pediatric and adult patients are limited. We analyzed the clinical, radiological and pathological features of 31 pediatric lymphomas involving the mediastinum, and compared them to the features of 21 adult patients. Although several histological subtypes were identified in adults, pediatric patients presented with T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia (T-LBL/T-ALL) and classical Hodgkin lymphomas (CHL) in 24 and 7 cases, respectively. Compared to adults, pediatric patients were more likely to be male (P = 0.089) and showed a higher incidence of T-LBL/T-ALL (P = 0.001), prevalence of dyspnea (P = 0.001), frequency of stage IV tumors (P = 0.008), and ratio of tumor diameter to maximum transthoracic diameter (P = 0.015). T-LBL/T-ALL patients presented with a higher frequency with stage IV disease (P = 0.000 and P = 0.001), compression of the blood vessels (P = 0.005 and P = 0.017), and pleural effusions (P = 0.001, for both) than CHL and PMBL patients. Compared to adults, pediatric patients with mediastinal lymphomas presented with exclusive histological subtypes of T-LBL/T-ALL and CHL, which showed distinctive characteristics of histological distribution, clinical presentation and radiological assessments.


Hodgkin Disease/diagnostic imaging , Lymphoma/diagnostic imaging , Mediastinum/diagnostic imaging , Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging , Adolescent , Adult , Child , Female , Hodgkin Disease/pathology , Humans , Lymphoma/classification , Lymphoma/pathology , Male , Mediastinum/pathology , Middle Aged , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/classification , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Young Adult
11.
J Biol Regul Homeost Agents ; 30(3): 871-875, 2016.
Article En | MEDLINE | ID: mdl-27655514

T-cell Acute Lymphoblastic Leukemia (T-cell ALL) is a rare haematological neoplasia, that affects children and less commonly adults. Female genital tract and particularly uterus involvement in acute ALL is rare. This report presents the CT features of a 64-year-old woman with uterine relapse of T-cell ALL, occurring 11 months after the diagnosis, as a second, unique relapse of disease. The patient was asymptomatic when a CT examination showed a homogenous thickness of the uterine wall in comparison with the previous CT examination. Histology from biopsy specimens, obtained through hysteroscopy, confirmed T-cell ALL localisation (TdT+, CD10+, CD3c+ and CD2+). The uterus could be a site of relapse in patients suffering from ALL. Even though an MRI examination could better demonstrate the disease in cases of suspected female genital tract involvement by ALL, the comparison of differences between a present and a previous CT examination is sufficient to suspect the diagnosis.


Leukemic Infiltration/diagnostic imaging , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging , Tomography, X-Ray Computed , Uterus/diagnostic imaging , Antigens, Differentiation, T-Lymphocyte/analysis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biopsy , Breast Neoplasms/drug therapy , DNA Nucleotidylexotransferase/analysis , Female , Humans , Hysteroscopy , Immunophenotyping , Middle Aged , Neoplasms, Second Primary , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology , T-Lymphocytes/chemistry , T-Lymphocytes/pathology
16.
Klin Oczna ; 116(3): 184-6, 2014.
Article Pl | MEDLINE | ID: mdl-25799782

The paper presents a case of a 60 year-old female referred to the Department of Ophthalmology and Ocular Oncology, Medical College, Jagiellonian University in Krakow with the sudden severe vision deterioration in both eyes. The patient was treated for T-cell acute lymphoblastic leukemia at the local Department of Hematology, at that time she was considered to be in hematological remission. Based on findings of clinical examination and additional tests, the patient was diagnosed with leukemic infiltration of the retina and optic nerve with secondary retinal detachment. Systemic and intrathecal chemotherapy as well as local radiotherapy to both eyes were administered. Ocular manifestations of T-cell acute lymphoblastic leukemia may develop in patients in hematological remission. Standard management of leukemic infiltrates involving the retina, choroid and optic nerve includes the intrathecal chemotherapy and lo- cal radiotherapy. Such therapy caused regression and cicatrization of the ocular infiltrates, but did not improve visual acuity in the described patient.


Leukemic Infiltration , Optic Disk/pathology , Optic Nerve Diseases/pathology , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/pathology , Female , Humans , Middle Aged , Optic Disk/radiation effects , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging , Radiography
17.
Cancer Imaging ; 12: 122-5, 2012 Apr 27.
Article En | MEDLINE | ID: mdl-22542798

We report a case of unexpected heterogeneous uptake of gadoxetic acid into a hepatic metastasis in a patient with T-cell lymphoblastic lymphoma that also lacked hypermetabolic characteristics on positron emission (PET)/computed tomography (CT) with [(18)F]fluorodeoxyglucose (FDG). Therefore, in cases of heterogeneous uptake of gadoxetic acid, infiltrative lesions must be considered.


Contrast Media/pharmacokinetics , Gadolinium DTPA/pharmacokinetics , Leukemic Infiltration/metabolism , Liver/pathology , Magnetic Resonance Imaging , Multimodal Imaging , Positron-Emission Tomography , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnostic imaging , Tomography, X-Ray Computed , Back Pain/etiology , Biopsy, Fine-Needle , Fluorine Radioisotopes , Fluorodeoxyglucose F18 , Humans , Leukemic Infiltration/diagnostic imaging , Liver/diagnostic imaging , Liver/metabolism , Male , Mediastinum/diagnostic imaging , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Radiopharmaceuticals , Young Adult
...